Generic placeholder image

Current Women`s Health Reviews

Editor-in-Chief

ISSN (Print): 1573-4048
ISSN (Online): 1875-6581

Research Article

The Relationship between Serum Oxytocin Levels and Sexual Function and Depression: A Cross-Sectional Study

Author(s): Zahra Ghorbani, Mojgan Mirghafourvand* and Sonia Hasani

Volume 19, Issue 1, 2023

Published on: 17 March, 2022

Article ID: e070122200089 Pages: 7

DOI: 10.2174/1573404818666220107110420

Price: $65

Abstract

Background: Inconsistent results were found regarding the relationship between human blood oxytocin (OXT) levels and psychiatric and sexual dysfunction (SD) in several studies.

Objective: The present study aimed to determine the relationship between OXT levels and sexual function and depression.

Methods: It was a cross-sectional study involving 84 non-pregnant healthy married women at childbearing age. Beck Depression Inventory and Female Sexual Function Index (FSFI) were used to collect the data, and human oxytocin ELISA kit was used to determine serum OXT level. The independent t-test and Pearson correlation coefficient were used to determine the relationship between variables.

Results: Average age of the participants was 36.1 (6.91) in this study and the range of their age was 19-49. The mean serum OXT level was 192.70 (139.71)pg/ml. The mean total score of FSFI and depression were 21.54 (5.18) and 12.42 (11.20) from the attainable score of 2-36 and 0-63, respectively. The associations between serum OXT level and FSFI overall score (r=0.066, P=0.548) and depression score (r=0.137, P=0.215) were not found to be significant. No statistically significant differences were found between the two groups of women with and without SD (P=0.155) and women with and without depression (P=0.110) in terms of serum OXT levels.

Conclusion: The results of this study did not indicate a significant relationship between serum OXT levels and depression and sexual function. As there was no significant relationship between the oxytocin concentrations and measured outcomes, conducting further studies with a better study design and a larger sample size is recommended.

Keywords: Sexual function, depression, oxytocin, Iran, cross-sectional study, ELISA.

Graphical Abstract
[1]
Ferrari AJ, Charlson FJ, Norman RE, et al. Burden of depressive disorders by country, sex, age, and year: Findings from the global burden of disease study 2010. PLoS Med 2013; 10(11): e1001547.
[http://dx.doi.org/10.1371/journal.pmed.1001547] [PMID: 24223526]
[2]
Balon R. Burden of sexual dysfunction. J Sex Marital Ther 2017; 43(1): 49-55.
[http://dx.doi.org/10.1080/0092623X.2015.1113597] [PMID: 26683616]
[3]
Polland AR, Davis M, Zeymo A, Iglesia CB. Association between comorbidities and female sexual dysfunction: Findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3). Int Urogynecol J Pelvic Floor Dysfunct 2019; 30(3): 377-83.
[http://dx.doi.org/10.1007/s00192-018-3739-7] [PMID: 30178126]
[4]
Tolentino JC, Schmidt SL. DSM-5 criteria and depression severity: Implications for clinical practice. Front Psychiatry 2018; 9: 450.
[http://dx.doi.org/10.3389/fpsyt.2018.00450] [PMID: 30333763]
[5]
Sungur MZ, Gündüz A. A comparison of DSM-IV-TR and DSM-5 definitions for sexual dysfunctions: Critiques and challenges. J Sex Med 2014; 11(2): 364-73.
[http://dx.doi.org/10.1111/jsm.12379] [PMID: 24251541]
[6]
Clayton AH, Valladares Juarez EM. Female sexual dysfunction. Med Clin North Am 2019; 103(4): 681-98.
[http://dx.doi.org/10.1016/j.mcna.2019.02.008] [PMID: 31078200]
[7]
Atlantis E, Sullivan T. Bidirectional association between depression and sexual dysfunction: A systematic review and meta-analysis. J Sex Med 2012; 9(6): 1497-507.
[http://dx.doi.org/10.1111/j.1743-6109.2012.02709.x] [PMID: 22462756]
[8]
McCabe MP, Sharlip ID, Lewis R, et al. Incidence and prevalence of sexual dysfunction in women and men: A consensus statement from the fourth international consultation on sexual medicine. 2015. J Sex Med 2016; 13(2): 144-52.
[http://dx.doi.org/10.1016/j.jsxm.2015.12.034] [PMID: 26953829]
[9]
Rothmore J. Antidepressant-induced sexual dysfunction. Med J Aust 2020; 212(7): 329-34.
[http://dx.doi.org/10.5694/mja2.50522] [PMID: 32172535]
[10]
Rutigliano G, Rocchetti M, Paloyelis Y, et al. Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis. Psychiatry Res 2016; 241: 207-20.
[http://dx.doi.org/10.1016/j.psychres.2016.04.117] [PMID: 27183106]
[11]
Neumann ID, Krömer SA, Toschi N, Ebner K. Brain oxytocin inhibits the (re)activity of the hypothalamo-pituitary-adrenal axis in male rats: Involvement of hypothalamic and limbic brain regions. Regul Pept 2000; 96(1-2): 31-8.
[http://dx.doi.org/10.1016/S0167-0115(00)00197-X] [PMID: 11102649]
[12]
Parker KJ, Schatzberg AF, Lyons DM. Neuroendocrine aspects of hypercortisolism in major depression. Horm Behav 2003; 43(1): 60-6.
[http://dx.doi.org/10.1016/S0018-506X(02)00016-8] [PMID: 12614635]
[13]
Ludwig M, Leng G. Dendritic peptide release and peptide-dependent behaviours. Nat Rev Neurosci 2006; 7(2): 126-36.
[http://dx.doi.org/10.1038/nrn1845] [PMID: 16429122]
[14]
Lippert TH, Mueck AO, Seeger H, Pfaff A. Effects of oxytocin outside pregnancy. Horm Res 2003; 60(6): 262-71.
[http://dx.doi.org/10.1159/000074243] [PMID: 14646403]
[15]
Viero C, Shibuya I, Kitamura N, et al. Review: Oxytocin: Crossing the bridge between basic science and pharmacotherapy. CNS Neurosci Ther 2010; 16(5): e138-56.
[http://dx.doi.org/10.1111/j.1755-5949.2010.00185.x] [PMID: 20626426]
[16]
Behnia B, Heinrichs M, Bergmann W, et al. Differential effects of intranasal oxytocin on sexual experiences and partner interactions in couples. Horm Behav 2014; 65(3): 308-18.
[http://dx.doi.org/10.1016/j.yhbeh.2014.01.009] [PMID: 24503174]
[17]
Burri A, Heinrichs M, Schedlowski M, Kruger TH. The acute effects of intranasal oxytocin administration on endocrine and sexual function in males. Psychoneuroendocrinology 2008; 33(5): 591-600.
[http://dx.doi.org/10.1016/j.psyneuen.2008.01.014] [PMID: 18375074]
[18]
Kruger THC, Deiter F, Zhang Y, et al. Effects of intranasal oxytocin administration on sexual functions in healthy women: A laboratory paradigm. J Clin Psychopharmacol 2018; 38(3): 239-42.
[http://dx.doi.org/10.1097/JCP.0000000000000863] [PMID: 29596150]
[19]
Muin DA, Sheikh Rezaei S, Tremmel-Scheinost M, et al. Men’s sexual response to female partner’s intranasal oxytocin administration for hypoactive sexual desire disorder: An open prospective cohort study. Fertil Steril 2017; 107(3): 781-787.e3.
[http://dx.doi.org/10.1016/j.fertnstert.2016.12.003] [PMID: 28189292]
[20]
Muin DA, Wolzt M, Marculescu R, et al. Effect of long-term intranasal oxytocin on sexual dysfunction in premenopausal and postmenopausal women: A randomized trial. Fertil Steril 2015; 104(3): 715-23.e4.
[http://dx.doi.org/10.1016/j.fertnstert.2015.06.010] [PMID: 26151620]
[21]
Zhang Y, Deiter F, Jung S, Heinrichs M, Schedlowski M, Kruger HC. Differential effects of intranasal oxytocin administration on sexual functions in healthy females: A laboratory setting. Eur Psychiatry 2015; 30: 264.
[http://dx.doi.org/10.1016/S0924-9338(15)30215-7]
[22]
Sansone A, Jannini EA, Romanelli F. Antioxidants in male sexual dysfunctions. Springer: Antioxidants in Andrology 2017; pp. 71-9.
[http://dx.doi.org/10.1007/978-3-319-41749-3_6]
[23]
Salim S. Oxidative stress and the central nervous system. J Pharmacol Exp Ther 2017; 360(1): 201-5.
[http://dx.doi.org/10.1124/jpet.116.237503] [PMID: 27754930]
[24]
Jankowski M, Bissonauth V, Gao L, et al. Anti-inflammatory effect of oxytocin in rat myocardial infarction. Basic Res Cardiol 2010; 105(2): 205-18.
[http://dx.doi.org/10.1007/s00395-009-0076-5] [PMID: 20012748]
[25]
Wang Y, Zhao S, Liu X, Zheng Y, Li L, Meng S. Oxytocin improves animal behaviors and ameliorates oxidative stress and inflammation in autistic mice. Biomed Pharmacother 2018; 107: 262-9.
[http://dx.doi.org/10.1016/j.biopha.2018.07.148] [PMID: 30098544]
[26]
Honceriu C, Ciobica A, Stoica B, Chirazi M, Padurariu M. Oxytocin antioxidant effects on Wistar rats. Rev Chim (Bucharest) 2016; 67: 2246-9.
[27]
Na K-S, Won E, Kang J, et al. Interaction effects of oxytocin receptor gene polymorphism and depression on hippocampal volume. Psychiatry Res Neuroimaging 2018; 282: 18-23.
[http://dx.doi.org/10.1016/j.pscychresns.2018.10.004] [PMID: 30384146]
[28]
Gregory SG, Connelly JJ, Towers AJ, et al. Genomic and epigenetic evidence for oxytocin receptor deficiency in autism. BMC Med 2009; 7(1): 62.
[http://dx.doi.org/10.1186/1741-7015-7-62] [PMID: 19845972]
[29]
Sánchez-Vidaña DI, Chan N-MJ, Chan AHL, et al. Repeated treatment with oxytocin promotes hippocampal cell proliferation, dendritic maturation and affects socio-emotional behavior. Neuroscience 2016; 333: 65-77.
[http://dx.doi.org/10.1016/j.neuroscience.2016.07.005] [PMID: 27418343]
[30]
Balmus I, Ciobica A, Stoica B, Lefter R, Cojocaru S, Reznikov A. Effects of oxytocin administration on oxidative markers in the temporal lobe of aged rats. Neurophysiology 2019; 51(1): 18-24.
[http://dx.doi.org/10.1007/s11062-019-09785-w]
[31]
Abedi P, Zohrabi I, Ansari S, Maraghi E, Maram NS, Houshmand G. The impact of oxytocin vaginal gel on sexual function in postmenopausal women: A randomized controlled trial. J Sex Marital Ther 2020; 46(4): 377-84.
[http://dx.doi.org/10.1080/0092623X.2020.1738606] [PMID: 32169019]
[32]
Torky HA, Taha A, Marie H, et al. Role of topical oxytocin in improving vaginal atrophy in postmenopausal women: a randomized, controlled trial. Climacteric 2018; 21(2): 174-8.
[http://dx.doi.org/10.1080/13697137.2017.1421924] [PMID: 29347848]
[33]
Al-Saqi SH, Jonasson AF, Naessén T, Uvnäs-Moberg K. Oxytocin improves cytological and histological profiles of vaginal atrophy in postmenopausal women. Post Reprod Health 2016; 22(1): 25-33.
[http://dx.doi.org/10.1177/2053369116629042] [PMID: 26883689]
[34]
Al-Saqi SH, Uvnäs-Moberg K, Jonasson AF. Intravaginally applied oxytocin improves post-menopausal vaginal atrophy. Post Reprod Health 2015; 21(3): 88-97.
[http://dx.doi.org/10.1177/2053369115577328] [PMID: 25995333]
[35]
Jonasson AF, Edwall L, Uvnäs-Moberg K. Topical oxytocin reverses vaginal atrophy in postmenopausal women: A double-blind randomized pilot study. Menopause Int 2011; 17(4): 120-5.
[http://dx.doi.org/10.1258/mi.2011.011030] [PMID: 22120944]
[36]
Ghassemzadeh H, Mojtabai R, Karamghadiri N, Ebrahimkhani N. Psychometric properties of a persian-language version of the beck depression inventory-second edition: BDI-II-Persian. Depress Anxiety 2005; 21(4): 185-92.
[http://dx.doi.org/10.1002/da.20070] [PMID: 16075452]
[37]
Fakhri A, Pakpour AH, Burri A, Morshedi H, Zeidi IM. The female sexual function index: Translation and validation of an Iranian version. J Sex Med 2012; 9(2): 514-23.
[http://dx.doi.org/10.1111/j.1743-6109.2011.02553.x] [PMID: 22146084]
[38]
Rosen RC, Taylor JF, Leiblum SR, Bachmann GA. Prevalence of sexual dysfunction in women: Results of a survey study of 329 women in an outpatient gynecological clinic. J Sex Marital Ther 1993; 19(3): 171-88.
[http://dx.doi.org/10.1080/00926239308404902] [PMID: 8246273]
[39]
Mohammadi K, Heydari M, Faghihzadeh S. The female sexual function index (FSFI): Validation of the Iranian version. Payesh 2008; 7(3): 0.
[40]
Parker KJ, Kenna HA, Zeitzer JM, et al. Preliminary evidence that plasma oxytocin levels are elevated in major depression. Psychiatry Res 2010; 178(2): 359-62.
[http://dx.doi.org/10.1016/j.psychres.2009.09.017] [PMID: 20494448]
[41]
Massey SH, Schuette SA, Pournajafi-Nazarloo H, Wisner KL, Carter CS. Interaction of oxytocin level and past depression may predict postpartum depressive symptom severity. Arch Women Ment Health 2016; 19(5): 799-808.
[http://dx.doi.org/10.1007/s00737-016-0616-6] [PMID: 26957508]
[42]
Lara-Cinisomo S, D’Anna-Hernandez K, Fujimoto EM, Pedersen CA. Exploring associations between perinatal depression, anxiety, and urinary oxytocin levels in Latinas. Arch Women Ment Health 2019; 22(4): 447-55.
[http://dx.doi.org/10.1007/s00737-018-0910-6] [PMID: 30191332]
[43]
Cyranowski JM, Hofkens TL, Frank E, Seltman H, Cai H-M, Amico JA. Evidence of dysregulated peripheral oxytocin release among depressed women. Psychosom Med 2008; 70(9): 967-75.
[http://dx.doi.org/10.1097/PSY.0b013e318188ade4] [PMID: 19005082]
[44]
Caruso S, Mauro D, Scalia G, Palermo CI, Rapisarda AMC, Cianci A. Oxytocin plasma levels in orgasmic and anorgasmic women. Gynecol Endocrinol 2018; 34(1): 69-72.
[http://dx.doi.org/10.1080/09513590.2017.1336219] [PMID: 28604123]
[45]
Wang T, Shi C, Li X, et al. Injection of oxytocin into paraventricular nucleus reverses depressive-like behaviors in the postpartum depression rat model. Behav Brain Res 2018; 336: 236-43.
[http://dx.doi.org/10.1016/j.bbr.2017.09.012] [PMID: 28889022]
[46]
Massey SH, Backes KA, Schuette SA. Plasma oxytocin concentration and depressive symptoms: A review of current evidence and directions for future research. Depress Anxiety 2016; 33(4): 316-22.
[http://dx.doi.org/10.1002/da.22467] [PMID: 26756305]
[47]
De Cagna F, Fusar-Poli L, Damiani S, et al. The role of intranasal oxytocin in anxiety and depressive disorders: A systematic review of randomized controlled trials. Clin Psychopharmacol Neurosci 2019; 17(1): 1-11.
[http://dx.doi.org/10.9758/cpn.2019.17.1.1] [PMID: 30690935]
[48]
Lang RE, Heil JW, Ganten D, Hermann K, Unger T, Rascher W. Oxytocin unlike vasopressin is a stress hormone in the rat. Neuroendocrinology 1983; 37(4): 314-6.
[http://dx.doi.org/10.1159/000123566] [PMID: 6633820]
[49]
Matsushita H, Latt HM, Koga Y, Nishiki T, Matsui H. Oxytocin and stress: Neural mechanisms, stress-related disorders, and therapeutic approaches. Neuroscience 2019; 417: 1-10.
[http://dx.doi.org/10.1016/j.neuroscience.2019.07.046] [PMID: 31400490]
[50]
Skrundz M, Bolten M, Nast I, Hellhammer DH, Meinlschmidt G. Plasma oxytocin concentration during pregnancy is associated with development of postpartum depression. Neuropsychopharmacology 2011; 36(9): 1886-93.
[http://dx.doi.org/10.1038/npp.2011.74] [PMID: 21562482]
[51]
Moura D, Canavarro MC, Figueiredo-Braga M. Oxytocin and depression in the perinatal period-a systematic review. Arch Women Ment Health 2016; 19(4): 561-70.
[http://dx.doi.org/10.1007/s00737-016-0643-3] [PMID: 27295067]
[52]
Thompson RJ, Parker KJ, Hallmayer JF, Waugh CE, Gotlib IH. Oxytocin receptor gene polymorphism (rs2254298) interacts with familial risk for psychopathology to predict symptoms of depression and anxiety in adolescent girls. Psychoneuroendocrinology 2011; 36(1): 144-7.
[http://dx.doi.org/10.1016/j.psyneuen.2010.07.003] [PMID: 20708845]
[53]
Jacobson JD, Ellerbeck KA, Kelly KA, et al. Evidence for alterations in stimulatory G proteins and oxytocin levels in children with autism. Psychoneuroendocrinology 2014; 40: 159-69.
[http://dx.doi.org/10.1016/j.psyneuen.2013.11.014] [PMID: 24485488]

Rights & Permissions Print Export Cite as
© 2024 Bentham Science Publishers | Privacy Policy